Jupiter Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
Other funds holding REGN
Jupiter Asset Management's REGN Position: Q2 2026 in Review
Jupiter Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 47,485% in Q2 2026, buying an estimated $85.7M and bringing the position to 126,099 shares worth $78.6M. The position accounts for 0.39% of the portfolio, ranked #72.
Jupiter Asset Management first reported a position in REGN in Q3 2020 and has held it in 10 quarters since. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Jupiter Asset Management held 126,099 shares of Regeneron Pharmaceuticals worth $78.6M as of Q2 2026.
- Jupiter Asset Management bought 125,834 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $85.7M.
- Regeneron Pharmaceuticals made up 0.39% of Jupiter Asset Management's portfolio in Q2 2026, its #72 holding.
- Jupiter Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2020 and has held it in 10 quarters since.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Jupiter Asset Management's 13F filing for Q2 2026, filed 10 Aug 2026.